Back to Results
First PageMeta Content
Cancer treatments / T cells / Tumor markers / Cancer immunotherapy / Immunotherapy / Carcinoembryonic antigen / Cancer / HLA-A / Squamous-cell carcinoma / Medicine / Immunology / Oncology


T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Target selection Steven A. Rosenberg, M.D., Ph.D.
Add to Reading List

Document Date: 2014-01-09 16:17:27


Open Document

File Size: 1,76 MB

Share Result on Facebook
UPDATE